The systemic factor: The comparative roles of cardiopulmonary bypass and off-pump surgery in the genesis of patient injury during and following cardiac surgery

Annals of Thoracic Surgery

Volumn 72, Issue 6, 2001, Pages

  Menasché, Philippe ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8;

CARDIOPULMONARY BYPASS; CELL TRANSPORT; COMORBIDITY; CONFERENCE PAPER; CORONARY ARTERY BYPASS GRAFT; DISEASE SEVERITY; EXTRACORPOREAL CIRCULATION; HEART INJURY; HEART LEFT VENTRICLE; HEREDITY; HUMAN; INFLAMMATION; KIDNEY FUNCTION; MEDIATOR RELEASE; NEUTROPHIL; PRIORITY JOURNAL; TISSUE INJURY;

CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; HUMANS; MONITORING, INTRAOPERATIVE; MYOCARDIAL INFARCTION; RISK FACTORS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0035665697     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(01)03286-6     Document Type: Conference Paper

References (56)

1. Beating versus arrested heart revascularization: Evaluation of myocardial function in a prospective randomized study
2. Inflammatory response and myocardial injury following coronary artery bypass grafting with or without cardiopulmonary bypass
3. Myocardial outflow of prostacyclin in relation to metabolic stress during off-pump coronary artery bypass grafting
4. Impact of left ventricular dysfunction on cytokines, hemodynamics, and outcome in bypass grafting
5. Comparison of myocardial revascularization without cardiopulmonary bypass to standard open heart technique in patients with left ventricular dysfunction
6. Of-pump versus on-pump coronary bypass in high-risk subgroups
7. Influence of temperature on neutrophil trafficking during clinical cardiopulmonary bypass
8. Effects of cardiopulmonary bypass on leucocyte and endothelial adhesion molecules
9. Induction of interleukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury
10. Endothelial cell binding of NAP-1/IL-8: Role in neutrophil emigration
11. Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury
12. Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations
13. Cytokines in myocardial injury: Impact on cardiac surgical approach
14. Genetic predisposition in patients undergoing cardiopulmonary bypass surgery is associated with an increase of inflammatory cytokines
15. Reduction of the inflammatory response in patients undergoing minimally invasive coronary artery bypass grafting
16. Off-pump bypass graft operation significantly reduces oxidative stress and inflammation
17. Complement activation in coronary artery bypass grafting patients without cardiopulmonary bypass: The role of tissue injury by surgical incision
18. Human cytokine responses to coronary artery, bypass grafting with and without cardiopulmonary bypass
19. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass
20. The effects of complement activation during cardiopulmonary bypass
21. Heparin and modified heparin inhibit complement activation in vivo
22. Effects of heparin and N-acetyl heparin on ischemia/reperfusion-induced alterations in myocardial fuction in the rabbit isolated heart
23. Organ dysfunction and cardiopulmonary bypass: The role of complement and complement regulatory proteins
24. Avoiding cardiopulmonary bypass in multivessel CABG reduces cytokine response and myocardial injury
25. Circulating soluble gp 130, soluble IL-6R, and IL-6 in patients undergoing cardiac surgery, with or without extracorporeal circulation
26. Humoral immune response during coronary artery bypass grafting. A comparison of limited approach, "off-pump" technique, and conventional cardiopulmonary bypass
27. Inhibition of interleukin-8 blocks myocardial ischemia-reperfusion injury
28. Interleukin-8 gene induction in the myocardium after ischemia, and reperfusion in vivo
29. Myocardial performance in elderly patients after cardiopulmonary bypass is suppressed by tumor necrosis factor
30. Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18)
31. Respiratory dysfunction after cardiac surgery: Effects of avoiding cardiopulmonary bypass and the use of bilateral internal mammary arteries
32. Does multivessel, off-pump coronary artery bypass reduce postoperative morbidity?
33. Systematic off-pump coronary artery revascularization in multivessel disease: Experience of three hundred cases
34. Effect of cardiopulmonary bypass on pulmonary gas exchange: A prospective randomized study
35. Drew-Anderson technique attenuates systemic inflammatory response syndrome and improves respiratory function after coronary artery bypass grafting
36. Reduction of proinflammatory cytokine levels and cellular adhesion in CABG procedures with separated pulmonary and systemic extracorporeal circulation without an oxygenator
37. Rapid recovery protocol applied to 5,658 consecutive "on-pump" coronary bypass patients
38. On-pump versus off-pump coronary revascularization: Evaluation of renal function
39. Trends in coronary artery bypass surgery results: A recent, 9-year study
40. Brain damage during cardiopulmonary bypass
41. Release of S100B during coronary artery bypass grafting is reduced by off-pump surgery
42. Off-pump coronary bypass operations significantly reduce S100 release: An indicator for less cerebral damage?
43. Neuromonitoring and neurocognitive outcome in off-pump versus conventional coronary bypass operation
44. Neurological outcome in coronary artery surgery with and without cardiopulmonary bypass
45. Is cardiopulmonary bypass still the cause of cognitive dysfunction after cardiac operations?
46. Cognitive effects after epidural vs general anesthesia in older adults
47. Neurocognitive dysfunction after coronary artery bypass surgery: A systematic review
48. Stroke in octogenarians undergoing coronary artery surgery with and without cardiopulmonary bypass
49. Myocardial revascularization in the elderly using beating heart coronary artery bypass surgery
50. Safety and efficacy of off-pump coronary artery bypass grafting
51. Neutrophil-endothelial cells modulation in diabetic patients undergoing coronary artery bypass grafting
52. Aprotinin and methylprednisolone equality blunt cardiopulmonary bypass-induced inflammation in humans
53. Modifying risk for extracorporeal circulation: Trial of four anti-inflammatory strategies
54. An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation
55. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IκB synthesis
56. Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass